Oral tyrosine kinase inhibitors targeting VEGF receptors, formulated as tablets for renal cell carcinoma and soft tissue sarcoma treatment. Utilized in oncology clinics and hospitals by oncologists and pharmacists. Manufactured by pharmaceutical companies, distributed through wholesalers to healthcare facilities for